Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 21, 2011

Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT)

  • Paul D'Orazio , Robert W. Burnett , Niels Fogh-Andersen , Ellis Jacobs , Katsuhiko Kuwa , Wolf R. Külpmann , Lasse Larsson , Andrzej Lewenstam , Anton H.J. Maas , Gerhard Mager , Jerzy W. Naskalski and Anthony O. Okorodudu

Abstract

In current clinical practice, plasma and blood glucose are used interchangeably with a consequent risk of clinical misinterpretation. In human blood, glucose is distributed, like water, between erythrocytes and plasma. The molality of glucose (amount of glucose per unit water mass) is the same throughout the sample, but the concentration is higher in plasma, because the concentration of water and therefore glucose is higher in plasma than in erythrocytes. Different devices for the measurement of glucose may detect and report fundamentally different quantities. Different water concentrations in the calibrator, plasma, and erythrocyte fluid can explain some of the differences. Results for glucose measurements depend on the sample type and on whether the method requires sample dilution or uses biosensors in undiluted samples. If the results are mixed up or used indiscriminately, the differences may exceed the maximum allowable error for glucose determinations for diagnosing and monitoring diabetes mellitus, thus complicating patient treatment. The goal of the International Federation of Clinical Chemistry and Laboratory Medicine, Scientific Division, Working Group on Selective Electrodes and Point of Care Testing (IFCC-SD-WG-SEPOCT) is to reach a global consensus on reporting results. The document recommends reporting the concentration of glucose in plasma (in the unit mmol/L), irrespective of sample type or measurement technique. A constant factor of 1.11 is used to convert concentration in whole blood to the equivalent concentration in plasma. The conversion will provide harmonized results, facilitating the classification and care of patients and leading to fewer therapeutic misjudgments.

Clin Chem Lab Med 2006;44:1486–90.


Corresponding author: Niels Fogh-Andersen, MD, Department of Clinical Biochemistry, Herlev Hospital, 2730 Herlev, Denmark Received for publication 2006-22-9

References

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.Search in Google Scholar

2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28(Suppl 1):S4–36.10.2337/diacare.28.suppl_1.S4Search in Google Scholar

3. Diabetes mellitus. Report of a WHO Study Group, World Health Organization Expert Committee. Technical Report Series 727. Geneva: WHO, 1985.Search in Google Scholar

4. Chance JF, Li DJ, Jones KA, Dyer KL, Nichols JH. Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol 1999; 111:547–56.10.1093/ajcp/111.4.547Search in Google Scholar

5. Johnson RN, Baker JR. Accuracy of devices used for self-monitoring of blood glucose. Ann Clin Biochem 1998; 35:68–74.10.1177/000456329803500108Search in Google Scholar

6. Kost GJ, et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 1998; 26:581–9.10.1097/00003246-199803000-00036Search in Google Scholar

7. Burrin JM, Alberti KG. What is blood glucose: can it be measured? Diabet Med 1990; 7:199–206.10.1111/j.1464-5491.1990.tb01370.xSearch in Google Scholar

8. Fogh-Andersen N, Wimberley PD, Thode J, Siggaard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clin Chim Acta 1990; 189:33–8.10.1016/0009-8981(90)90232-HSearch in Google Scholar

9. Fogh-Andersen N, D'Orazio P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem 1998; 44:655–9.10.1093/clinchem/44.3.655Search in Google Scholar

10. Siggaard-Andersen O, Durst RA, Maas AHJ. Physicochemical quantities and units in clinical chemistry with special emphasis on activities and activity coefficients. IUPAC/IFCC recommendation. J Clin Chem Clin Biochem 1987; 25:369–91; Ann Biol Clin 1987; 45:89–109.Search in Google Scholar

11. Stahl M, Brandslund I, Jorgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest 2002; 62:159–66.10.1080/003655102753611799Search in Google Scholar PubMed

12. American Diabetes Association. Consensus statement – self monitoring of blood glucose. Diabetes Care 1990;13(Suppl 1):41–6.10.2337/diacare.13.1.S41Search in Google Scholar

13. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 1994;17:81–6.10.2337/diacare.17.1.81Search in Google Scholar PubMed

14. Rainey PM, Jatlow P. Monitoring blood glucose meters [editorial]. Am J Clin Pathol 1995; 103:125–6.10.1093/ajcp/103.2.125Search in Google Scholar PubMed

Published Online: 2011-9-21
Published in Print: 2006-12-1

©2006 by Walter de Gruyter Berlin New York

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2006.275/html
Scroll to top button